Scynexis (SCYX) Accumulated Expenses (2013 - 2026)
Scynexis (SCYX) posted Accumulated Expenses of $1.5 million for Q1 2026, up 1.46% on a QoQ basis from $1.5 million in Q4 2025, and down 41.86% year-over-year from $2.6 million in Q1 2025.
Scynexis (SCYX) Accumulated Expenses (2013 - 2026) Analysis & Trends
Scynexis' Accumulated Expenses history runs 14 years deep, the most recent figure standing at $1.5 million for Q1 2026.
- Quarterly Accumulated Expenses fell 41.86% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (down 41.86% YoY) and the FY2025 annual result came in at $1.5 million, down 60.27% from the prior year.
- Accumulated Expenses was $1.5 million for Q1 2026 at Scynexis, up from $1.5 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $9.5 million in Q3 2023 and bottomed at $453000.0 in Q1 2024.
- A 5-year average of $3.3 million and a median of $2.5 million in 2025 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Accumulated Expenses soared 944.57% — and 2024, when it tumbled 90.51%.
- Scynexis' Accumulated Expenses stood at $5.6 million in 2022, then plunged by 69.94% to $1.7 million in 2023, then soared by 124.17% to $3.8 million in 2024, then plunged by 60.27% to $1.5 million in 2025, then gained by 1.46% to $1.5 million in 2026.
- Business Quant data shows SCYX's Accumulated Expenses at $1.5 million in Q1 2026, $1.5 million in Q4 2025, and $1.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.53 Mn |
| Dec 31, 2025 | 1.51 Mn |
| Sep 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | 2.48 Mn |
| Mar 31, 2025 | 2.63 Mn |
| Dec 31, 2024 | 3.79 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 5.50 Mn |
| Mar 31, 2024 | 453,000.00 |
| Dec 31, 2023 | 1.69 Mn |
| Sep 30, 2023 | 9.54 Mn |
| Jun 30, 2023 | 7.19 Mn |
| Mar 31, 2023 | 4.78 Mn |
| Dec 31, 2022 | 5.63 Mn |
| Sep 30, 2022 | 1.82 Mn |
| Jun 30, 2022 | 1.16 Mn |
| Mar 31, 2022 | 4.52 Mn |
| Dec 31, 2021 | 5.70 Mn |
| Sep 30, 2021 | 1.51 Mn |
| Jun 30, 2021 | 3.37 Mn |